View in EDS HTML Full Text PDF Full Text

PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Saved in:

Bibliographic Details
Title:	PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Authors:	Gąsowska-Bodnar, Agnieszka¹ (AUTHOR) agnieszka.gasowska-bodnar@uws.edu.pl, Gąsowska-Bajger, Beata² (AUTHOR), Żołnierek, Aleksandra³ (AUTHOR), Żołnierek, Jakub¹ (AUTHOR), Bodnar, Lubomir^1,2 (AUTHOR)
Source:	Cancers. Apr2026, Vol. 18 Issue 8, p1226. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20726694
DOI:	10.3390/cancers18081226